等待開盤 09-23 09:30:00 美东时间
-5.160
-4.99%
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-22 21:50
Abivax SA (NASDAQ:ABVX) reported mixed results for the first half of the year on Monday. The company posted losses of $2.43 per share, compared to the analyst consensus estimate of losses of $1.08 per share. The company reported sales of $2.959 million which beat the analyst consensus estimate of $1...
09-22 21:28
Wedbush analyst David Nierengarten maintains Abivax (NASDAQ:ABVX) with a Neutral and lowers the price target from $140 to $118.
09-22 20:40
Abivax (NASDAQ:ABVX) reported quarterly losses of $(2.43) per share which missed the analyst consensus estimate of $(1.08) by 125 percent. This is a 65.31 percent decrease over losses of $(1.47) per share from the same period last year. The company reported quarterly sales of $2.959 million which be...
09-22 04:40
Companies Reporting Before The Bell • Ennis (NYSE:EBF) is expected to report earnings for its second quarter. Companies Reporting After The Bell • Abivax (NASDAQ:ABVX) is projected to report quarterly loss at $1.08 per share on revenue of $1.86 million. This article was generated by Benzinga's autom...
09-21 19:11
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Friday. U.S. stocks settled mixed on Friday, with the Nasdaq Composite gaining more than 100 points during the session. However, the Dow Jones index settled lowe...
09-21 14:47
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Abivax SA (NASDAQ:ABVX) to post a first-half loss of $1.08 per share on revenue of $1.86 million after the closing bell, according to data from Ben...
09-21 14:06
AI医疗概念周内狂飙!Tempus AI劲升32%,CEO释放长期增长指引;TWST升31%,与礼来TuneLab达成合作;FPS升24%,2027财年业绩指引大超预期>>
09-20 09:30
今日重点评级关注:康托·菲茨杰拉德:维持SOL Strategies"超配"评级,目标价从2.8美元升至6.2美元;康托·菲茨杰拉德:维持Sui Group Holdings"超配"评级,目标价从1.7美元升至3.4美元
09-11 14:30
Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $155.
09-10 17:14